Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Human P2X7 receptor causes cycle arrest in RPMI-8226 myeloma cells to alter the interaction with osteoblasts and osteoclasts

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. IL-6, IL-12, and IL-23 STAT-Pathway Genetic Risk and Responsiveness of Lymphocytes in Patients with Multiple Sclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The Value of 68Ga-PSMA PET/CT Following Equivocal 18F-NaF PET/CT in Prostate Cancer Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Varicocele Testis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Contemporary Thoughts on the Role of Shockwave Therapy in Peyronie's Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Ejakulationsforstyrrelser

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Marianne Trier Bjerre
  • Maibritt Nørgaard
  • Ole Halfdan Larsen
  • Sarah Østrup Jensen
  • Siri H Strand
  • Peter Østergren
  • Mikkel Fode
  • Jacob Fredsøe
  • Benedicte Parm Ulhøi
  • Martin Mørck Mortensen
  • Jørgen Bjerggaard Jensen
  • Michael Borre
  • Karina D Sørensen
Vis graf over relationer

Novel and minimally-invasive prostate cancer (PCa)-specific biomarkers are needed to improve diagnosis and risk stratification. Here, we investigated the biomarker potential in localized and de novo metastatic PCa (mPCa) of methylated circulating tumor DNA (ctDNA) in plasma. Using the Marmal-aid database and in-house datasets, we identified three top candidates specifically hypermethylated in PCa tissue: DOCK2,HAPLN3, and FBXO30 (specificity/sensitivity: 80%-100%/75-94%). These candidates were further analyzed in plasma samples from 36 healthy controls, 61 benign prostatic hyperplasia (BPH), 102 localized PCa, and 65 de novo mPCa patients using methylation-specific droplet digital PCR. Methylated ctDNA for DOCK2/HAPLN3/FBXO30 was generally not detected in healthy controls, BPH patients, nor in patients with localized PCa despite a positive signal in 98%-100% of matched radical prostatectomy tissue samples. However, ctDNA methylation of DOCK2,HAPLN3, and/or FBXO30 was detected in 61.5% (40/65) of de novo mPCa patients and markedly increased in high- compared to low-volume mPCa (89.3% (25/28) vs. 32.1% (10/31), p < 0.001). Moreover, detection of methylated ctDNA was associated with significantly shorter time to progression to metastatic castration resistant PCa, independent of tumor-volume. These results indicate that methylated ctDNA (DOCK2/HAPLN3/FBXO30) may be potentially useful for identification of hormone-naïve mPCa patients who could benefit from intensified treatment.

OriginalsprogEngelsk
TidsskriftCells
Vol/bind9
Udgave nummer6
ISSN2073-4409
DOI
StatusUdgivet - 31 maj 2020

ID: 60069184